SinomedTrip
← Back to articles
6 min read
SinomedTrip Team

No Stitches Needed: Tangdu Hospital's 3D-Printed Patch Seals Intestinal Wounds and Prevents Leakage

Researchers at Tangdu Hospital published a breakthrough in Theranostics — a 3D-printed asymmetric bioadhesive patch that repairs intestinal tissue without sutures, prevents the deadly complication of anastomotic leakage, and blocks post-surgical adhesions.

Medically reviewed by SinomedTrip's clinical team

The Innovation That Could Make Intestinal Surgery Leakage a Thing of the Past

Anastomotic leakage — when a surgical connection between two segments of intestine fails to seal — is one of the most feared complications in gastrointestinal surgery. It occurs in 5-20% of colorectal procedures, can lead to life-threatening peritonitis and sepsis, and carries mortality rates of 10-30%.

Despite decades of surgical refinement, no technology has reliably solved this problem. Sutures and staples hold tissue together mechanically but don't promote biological healing at the junction. When they fail, the consequences are catastrophic.

Now, a research team at Tangdu Hospital (Air Force Medical University, Xi'an) has published a potential game-changer: a 3D-printed asymmetric bioadhesive patch (ABP) that seals intestinal wounds without sutures, prevents leakage, and simultaneously blocks the post-surgical adhesions that cause chronic pain and bowel obstruction.

The study was published in Theranostics — a top-tier journal ranked JCR Q1 and Chinese Academy of Sciences Zone 1.

Tangdu Hospital 3D Printed Bioadhesive Patch

The Problem: Two Complications, One Surgery

After any intestinal surgery — whether for cancer, Crohn's disease, diverticulitis, or trauma — surgeons must reconnect the cut ends of the bowel. This connection (anastomosis) faces two major threats:

ComplicationWhat HappensIncidenceConsequence
Anastomotic leakageThe connection fails; intestinal contents spill into the abdomen5-20%Peritonitis, sepsis, emergency reoperation, death (10-30%)
Post-operative adhesionScar tissue bands form between organs, binding them togetherUp to 90%Chronic pain, bowel obstruction, infertility, need for further surgery

Current solutions address one problem but often worsen the other. Tissue glues can seal leaks but may cause inflammation that promotes adhesions. Anti-adhesion barriers prevent scarring but don't strengthen the anastomosis.

The Tangdu Solution: One Patch, Two Functions

The research team, led by Dr. Li Qianwei (Deputy Director, Ultrasound Diagnostics / 3D Printing Research Center) and Dr. Yuan Liyun (Director, Ultrasound Diagnostics), engineered a patch with two fundamentally different surfaces:

Inner surface (intestine-facing):

  • Strong bioadhesion — Bonds firmly to wet intestinal tissue without sutures or staples
  • Antibacterial properties — Kills bacteria at the wound site, reducing infection risk
  • Promotes tissue regeneration — Contains bioactive factors that accelerate healing of the anastomosis

Outer surface (abdomen-facing):

  • Anti-adhesion barrier — Smooth, non-stick surface that prevents surrounding organs and tissues from binding to the surgical site
  • Biodegradable — Dissolves naturally after healing is complete, leaving no permanent foreign material

This asymmetric design — sticky on one side, slippery on the other — is what makes the patch unique. It simultaneously strengthens the anastomosis AND prevents the adhesions that plague conventional surgery.

Why 3D Printing Is Critical

The patch is manufactured using 3D printing technology, which provides advantages that traditional manufacturing cannot match:

  • Precision architecture — The internal microstructure can be precisely controlled to optimize adhesion strength, drug delivery, and degradation rate
  • Customizability — Patches can potentially be printed to match the exact size and curvature of individual patients' anatomy
  • Reproducibility — Every patch is identical, ensuring consistent clinical performance
  • Scalability — 3D printing enables efficient mass production once the technology moves to clinical use

Research Team

From Lab to Bedside: What This Means for Patients

While this technology is currently at the research stage, its clinical implications are profound. If successfully translated to human use, the bioadhesive patch could:

  • Reduce anastomotic leakage rates from 5-20% toward near-zero
  • Eliminate the need for protective stomas — temporary colostomies currently used to protect high-risk anastomoses
  • Prevent adhesion-related readmissions — currently accounting for 30% of emergency bowel obstruction cases
  • Shorten hospital stays — by reducing the most common reason for prolonged post-operative monitoring

Current GI Surgery Cost: China vs Western Countries

ProcedureChina (Tangdu Hospital)United States
Laparoscopic colectomy$8,000 - $15,000$40,000 - $80,000
Anastomotic leakage repair (emergency)$10,000 - $20,000$50,000 - $120,000
Adhesion-related bowel obstruction surgery$5,000 - $12,000$25,000 - $60,000
Protective stoma creation + reversal$6,000 - $12,000$30,000 - $50,000

China prices include surgery, hospital stay, and post-operative care.

Why China Is Leading in Surgical Biomaterials Research

This publication is part of a broader trend: Chinese research institutions are producing an increasing share of the world's most impactful surgical innovation. Tangdu Hospital's 3D Printing Research Center has published across multiple top-tier journals including Theranostics, ACS Applied Science & Interface, Frontiers in Bioengineering, and Advanced Functional Materials.

For international patients, this research pipeline means that China's top hospitals are not just adopting global best practices — they are creating the next generation of surgical technologies that will eventually be used worldwide.

About Tangdu Hospital

Tangdu Hospital is one of two flagship hospitals of the Air Force Medical University in Xi'an:

  • 3D Printing Research Center combining engineering, biomaterials science, and clinical surgery
  • Ultrasound Diagnostics Department led by Dr. Yuan Liyun with cross-disciplinary research capabilities
  • Strong research output in biomaterials, tissue engineering, and surgical innovation
  • Located in Xi'an — SinomedTrip's home city, enabling seamless coordination for international patients

China's top hospitals are not just performing world-class surgery — they're inventing the future of it. Explore treatment options →

Frequently Asked Questions

Is the 3D-printed bioadhesive patch available for patients now?

The bioadhesive patch is currently at the preclinical research stage and is not yet available for patient use. However, Tangdu Hospital offers all current best-practice techniques for intestinal surgery, including advanced stapling devices and anti-adhesion barriers. Clinical trials for the patch technology may begin in the coming years.

What are the current options to prevent anastomotic leakage during intestinal surgery?

Current strategies include meticulous surgical technique, reinforcing staple lines, using protective stomas (temporary colostomies) for high-risk anastomoses, and optimizing patient nutrition before surgery. Tangdu Hospital's surgical team applies all of these approaches and has extensive experience in both laparoscopic and open colorectal procedures.

Why should I consider having gastrointestinal surgery in China?

China's top surgical centers perform very high volumes of GI procedures, which translates to greater surgeon experience and better outcomes. Costs are typically 70-80% lower than in the US for equivalent procedures. Additionally, hospitals like Tangdu are at the forefront of surgical innovation, meaning patients benefit from the latest techniques and technologies.

How do I arrange a consultation with the surgical team at Tangdu Hospital from overseas?

SinomedTrip can arrange a telemedicine consultation where you share your medical records and imaging with the Tangdu Hospital surgical team. The surgeon will review your case, discuss treatment options, and provide a preliminary plan including estimated costs and length of stay. This initial consultation is typically completed within one week of submitting your records.

What is the typical hospital stay after laparoscopic colorectal surgery at Tangdu Hospital?

Most patients stay 5 to 10 days after laparoscopic colorectal surgery at Tangdu Hospital, depending on the complexity of the procedure and individual recovery. The hospital provides comprehensive post-operative monitoring including imaging and blood work before discharge. SinomedTrip arranges nearby hotel accommodation for the recovery period after hospital discharge.

Does Tangdu Hospital have English-speaking staff for international patients?

While Tangdu Hospital's primary language is Chinese, SinomedTrip provides dedicated English-speaking medical coordinators who accompany international patients to all appointments, translate medical discussions in real time, and help with daily needs throughout the hospital stay. Tangdu Hospital is located in Xi'an, which is SinomedTrip's home city, enabling especially close coordination.


Need advanced gastrointestinal surgical care? Request a free consultation →

This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider for diagnosis and treatment decisions.

Related Articles

World-First Trial: PUMCH Proves New Drug Combination Nearly Doubles Response Rates in Aplastic Anemia

PUMCH's hematology team published the first-ever randomized trial showing luspatercept plus cyclosporine achieves 79% response rates in non-transfusion-dependent aplastic anemia — nearly double the standard treatment, especially in elderly patients.

Read More

Not All Cervical Cancers Are Equal: PUMCH Research Shows Why Immunotherapy Works for Some Patients but Not Others

PUMCH's gynecologic oncology team published research revealing that cervical cancer subtypes have fundamentally different immune environments — explaining why PD-1 inhibitors work well for squamous cell carcinoma but fail in adenocarcinoma and neuroendocrine types.

Read More

PUMCH Maps the 'Culprit Cells' Behind Heart Attacks — Published in Nature Communications

PUMCH's vascular surgery team co-led a 169-patient study identifying two stem cell subtypes in arterial fat tissue that cause atherosclerotic plaques to rupture — the mechanism behind most heart attacks and strokes.

Read More

China's First Homegrown ALS Gene Therapy Achieves 69% Protein Reduction — Published in Nature Medicine

Beijing Tiantan Hospital's neurology team developed RAG-17, China's first domestically developed siRNA drug for ALS, which reduced toxic SOD1 protein by up to 69% in a Phase 1 trial — results published in Nature Medicine.

Read More